1,4-Oxazepines as BACE1 and/or BACE2 inhibitors
US8877744B2 · kind B2 · utility
2Cited by
0References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 28, 2012 |
| Grant date | Nov 4, 2014 |
| Priority date | — |
| Expiry date | Dec 5, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to 1,4 Oxazepines of formula Ihaving BACE1 and/or BACE2 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e.g. Alzheimer's disease and type 2 diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.